A detailed history of Morgan Stanley transactions in Gyrodyne, LLC stock. As of the latest transaction made, Morgan Stanley holds 811 shares of GYRO stock, worth $6,585. This represents 0.0% of its overall portfolio holdings.

Number of Shares
811
Previous 37,444 97.83%
Holding current value
$6,585
Previous $374,000 98.4%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$7.93 - $10.0 $290,499 - $366,330
-36,633 Reduced 97.83%
811 $6,000
Q4 2023

Feb 13, 2024

BUY
$8.95 - $10.58 $333,172 - $393,851
37,226 Added 17076.15%
37,444 $374,000
Q4 2022

Feb 14, 2023

SELL
$8.1 - $10.0 $4,860 - $6,000
-600 Reduced 73.35%
218 $1,000
Q2 2022

Oct 27, 2022

BUY
$12.01 - $13.18 $456 - $500
38 Added 4.87%
818 $9,000
Q2 2022

Aug 15, 2022

BUY
$12.01 - $13.18 $456 - $500
38 Added 4.87%
818 $9,000
Q1 2022

Oct 27, 2022

SELL
$11.5 - $14.01 $437 - $532
-38 Reduced 4.65%
780 $11,000
Q3 2021

Nov 15, 2021

BUY
$12.0 - $13.54 $9,360 - $10,561
780 New
780 $10,000

Others Institutions Holding GYRO

About Gyrodyne, LLC


  • Ticker GYRO
  • Exchange NASDAQ
  • Sector Real Estate
  • Industry Real Estate Services
  • Shares Outstandng 1,482,680
  • Market Cap $12M
  • Description
  • Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.
More about GYRO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.